From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tom Winnifrith Bearcast: who will win the US election this year and why it matters

By Tom Winnifrith | Monday 8 June 2020


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


You may not like my joy at Donald Trump beating crooked Hillary Clinton in 2016 but I called the vote correctly and explained in detail how and why I thought The Donald would win. It matters big time for equity investors who wins the General Election in November but also who triumphs in House and Senate races. I offer up my first detailed thoughts. Then I look at Amigo (AMGO), Intu (INTU), Novacyt (NCYT), Avacta (AVCT) and Open Orphan (ORPH). Finally, we are now at an amazing 65% of our keep Woodlarks alive rogue bloggers appeal target. With my big walk now just 5 days away thank you to those listeners who have donated. To those who have not please do so HERE.

You must be a paid subscriber to listen to Bearcast
ShareProphets is reader-supported journalism

Join us for free and gain access to three articles per month

Or become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 09:40:54